argenx SE | 营业费用



Operating Expenses 更改 日
AstraZeneca USD 10.95B 1.04B 2025-06
Galapagos EUR 122.32M 111.37M 2025-06
Genmab DKK 565M 38M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
GRIFOLS EUR 1.54B 24.64M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Qiagen NV USD 397.57M 39.27M 2025-06
UCB EUR 2.36B 108M 2024-12


argenx SE 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.